Breathe Well Live Well
|
Channel blocker treats asthma in the lab
Baylor College of Medicine News Today, in a recent edition of the Journal of Biological Chemistry, Beeton has shown that the synthetic analog, known as ShK-186, can inhibit the function of allergen-specific T lymphocytes from patients with asthma and in a rat model. T lymphocytes (a … |
View full post on asthma – Google News
|
IL-13 Blocker Helps Asthma Control
MedPage Today Explain that asthma patients with poorly controlled symptoms on inhaled steroids had significant improvement in lung function during 12 weeks of treatment with an investigational interleukin-13 (IL-13) … Experimental Drug Promising Against Tough-to-Treat Asthma Roche asthma drug shows promise in mid-stage trial Roche's Lebrikizumab Improved Lung Function in Asthma Study |
View full post on asthma – Google News